Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 24, 2025 08:55 ET | Source: SNS Insider pvt ltd

Viral Vector Manufacturing Market to Surpass USD 10.65 Billion by 2033, Driven by Surging Gene Therapy Pipelines and Advanced Vector Engineering | SNS Insider

Austin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Viral Vector Manufacturing Market Size & Growth Analysis: According to a comprehensive report by SNS Insider, the Viral Vector Manufacturing Market...
November 13, 2025 08:00 ET | Source: Genosafe

GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes

GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes Évry-Courcouronnes, le...
November 13, 2025 08:00 ET | Source: Genosafe

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector Évry-Courcouronnes, France, November 16th, 2025...
October 23, 2025 09:00 ET | Source: BioBridge Global

BBG Advanced Therapies collects first cell donation on one-of-a-kind bus

San Antonio, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The world’s only mobile leukapheresis center recorded its first donation on Monday, Oct. 20, marking the beginning of a new era for global...
October 08, 2025 03:00 ET | Source: BioBridge Global

BBG Advanced Therapies and CELLforCURE Partner to Provide Transatlantic Manufacturing Solutions for Advanced Therapy Medicinal Products (ATMPs)

San Antonio, Texas, Oct. 08, 2025 (GLOBE NEWSWIRE) -- BBG Advanced Therapies, a subsidiary of BioBridge Global (San Antonio, Texas, USA), and CELLforCURE, part of SEQENS Group, (Les Ulis, France)...
October 07, 2025 08:26 ET | Source: BioBridge Global

BBG Advanced Therapies and CELLforCURE Partner to Provide Transatlantic Manufacturing Solutions for Advanced Therapy Medicinal Products (ATMPs)

San Antonio, Texas, Oct. 07, 2025 (GLOBE NEWSWIRE) -- BBG Advanced Therapies, a subsidiary of BioBridge Global (San Antonio, Texas, USA), and CELLforCURE, part of SEQENS Group, (Les Ulis, France)...
October 06, 2025 07:05 ET | Source: 4Bio Capital

4BIO Capital founded Trogenix secures £70 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers

Trogenix was founded by 4BIO as a spinout from the University of Edinburgh alongside Professor Steve Pollard and Dr Ken Macnamara in 2023Trogenix's breakthrough Odysseus® platform targets cancer cells...
October 06, 2025 02:05 ET | Source: 4Bio Capital

4BIO Capital founded Trogenix secures £70 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers

Trogenix was founded by 4BIO as a spinout from the University of Edinburgh alongside Professor Steve Pollard and Dr Ken Macnamara in 2023Trogenix's breakthrough Odysseus® platform targets cancer cells...
September 24, 2025 10:07 ET | Source: Pluristyx, Inc.

Pluristyx and Solesis Announce Strategic Collaboration to Advance Organoid and Cell Therapy Solutions

Pluristyx and Solesis partner to launch game-changing standardized organoid kits, powered by iPSC and polymer technologies.
September 04, 2025 07:07 ET | Source: Pluristyx, Inc.

Pluristyx and BioLamina Announce Strategic Partnership to Accelerate Development of Stem Cell-Based Therapies

Pluristyx & BioLamina partner to accelerate iPSC-based therapies with integrated cell culture solutions, for consistency, scalability & clinical success.